Skip to content
- The spectrum of BRCA1 and BRCA2 mutations and clinicopathological characteristics in Chinese women with early-onset breast cancer.
- Chen L, Fu F, Huang M, Lv J, Zhang W, Wang C.
- Breast Cancer Res Treat. 2020 Feb 18. doi: 10.1007/s10549-020-05573-x. [Epub ahead of print]
- Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer.
- Wong EM, Southey MC, Terry MB.
- Br J Cancer. 2020 Feb 18. doi: 10.1038/s41416-019-0720-2. [Epub ahead of print]
- Disparities in BRCA counseling across providers in a diverse population of young breast cancer survivors.
- Reid S, Cragun D, Tezak A, Weidner A, Moore J, Mayer IA, Shu X, Ye F, Fan R, Vadaparampil S, Pal T.
- Genet Med. 2020 Feb 18. doi: 10.1038/s41436-020-0762-0. [Epub ahead of print]